Novel biomarkers in major depression

Purpose of review This article reviews literature published over the period January 2011–June 2012 on biomarkers in major depression. Recent findings Although a large body of research accumulated over the past decades points to distinct biological mechanisms being involved in the pathophysiology of major depressive disorder (MDD), its precise pathobiology is not yet fully understood. In the last 2 years, substantial new research has been generated in an attempt to identify and characterize novel candidate biomarkers for MDD. This review provides an update on biomarker research in MDD and summarizes the most recent results from neuroimaging, genetic, epigenetic, and neurochemical studies in MDD. Summary Promising new findings report high diagnostic accuracy for metabonomic and epigenetic approaches as well as combinatorial functional neuroimaging approaches, which are currently representing the forefront of MDD biomarker development.

[1]  Eva Meisenzahl,et al.  Structural MRI correlates for vulnerability and resilience to major depressive disorder. , 2011, Journal of psychiatry & neuroscience : JPN.

[2]  Gregor Hasler,et al.  Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study. , 2011, The American journal of psychiatry.

[3]  Wang Xiang,et al.  Elevated amygdala activity to negative faces in young adults with early onset major depressive disorder , 2012, Psychiatry Research: Neuroimaging.

[4]  Hans-Jürgen Möller,et al.  Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. , 2007, Archives of general psychiatry.

[5]  A. Schene,et al.  Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study. , 2012, The Journal of clinical psychiatry.

[6]  Allan L Reiss,et al.  Aberrant brain activation during a working memory task in psychotic major depression. , 2011, The American journal of psychiatry.

[7]  Sergi G. Costafreda,et al.  Predictive neural biomarkers of clinical response in depression: A meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies , 2013, Neurobiology of Disease.

[8]  Alan J. Thomas,et al.  White matter changes in late-life depression: a diffusion tensor imaging study. , 2011, Journal of affective disorders.

[9]  G. Dichter,et al.  Major depressive disorder is characterized by greater reward network activation to monetary than pleasant image rewards , 2011, Psychiatry Research: Neuroimaging.

[10]  L. Fañanás,et al.  Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression , 2011, Psychopharmacology.

[11]  R. Kahn,et al.  Region and state specific glutamate downregulation in major depressive disorder: A meta-analysis of 1H-MRS findings , 2012, Neuroscience & Biobehavioral Reviews.

[12]  S. Beach,et al.  The relationship of deiodinase 1 genotype and thyroid function to lifetime history of major depression in three independent populations , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[13]  J. Diego-Adeliño,et al.  Ventromedial prefrontal spectroscopic abnormalities over the course of depression: a comparison among first episode, remitted recurrent and chronic patients. , 2011, Journal of psychiatric research.

[14]  N. Wray,et al.  Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned , 2010, Molecular Psychiatry.

[15]  K. Lesch,et al.  Integrating neurobiological markers of depression. , 2010, Archives of general psychiatry.

[16]  G. MacQueen,et al.  Abnormal hippocampal activation in patients with extensive history of major depression: an fMRI study. , 2012, Journal of psychiatry & neuroscience : JPN.

[17]  Fei Wang,et al.  Whiter matter abnormalities in medication-naive subjects with a single short-duration episode of major depressive disorder , 2011, Psychiatry Research: Neuroimaging.

[18]  Florian Schubert,et al.  Abnormal Cingulate and Prefrontal Cortical Neurochemistry in Major Depression After Electroconvulsive Therapy , 2011, Biological Psychiatry.

[19]  Peng Xie,et al.  Plasma metabonomics as a novel diagnostic approach for major depressive disorder. , 2012, Journal of proteome research.

[20]  J. Hauser,et al.  Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorder. , 2011, Journal of affective disorders.

[21]  M. Mallar Chakravarty,et al.  Longitudinal MR study of brain structure and hippocampus volume in major depressive disorder , 2011, Acta psychiatrica Scandinavica.

[22]  Felipe Fregni,et al.  A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. , 2008, The international journal of neuropsychopharmacology.

[23]  R. Duman,et al.  Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications , 2008, Biological Psychiatry.

[24]  C. Simonsen,et al.  Longitudinal MRI study of cortical thickness, perfusion, and metabolite levels in major depressive disorder , 2011, Acta psychiatrica Scandinavica.

[25]  K. Coburn,et al.  Association of the brain-derived neurotrophic factor Val66Met polymorphism with hippocampus volumes in drug-free depressed patients , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[26]  J. Neumaier,et al.  Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder , 2011, Psychopharmacology.

[27]  B. Franke,et al.  Serum brain-derived neurotrophic factor: Determinants and relationship with depressive symptoms in a community population of middle-aged and elderly people , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[28]  Keith Matthews,et al.  Prediction of illness severity in patients with major depression using structural MR brain scans , 2012, Journal of magnetic resonance imaging : JMRI.

[29]  Joaquim Radua,et al.  Depression is associated with increased sensitivity to signals of disgust: a functional magnetic resonance imaging study. , 2010, Journal of psychiatric research.

[30]  Peter McGuffin,et al.  Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies. , 2011, Journal of affective disorders.

[31]  Guillén Fernández,et al.  Amygdala responsivity related to memory of emotionally neutral stimuli constitutes a trait factor for depression , 2011, NeuroImage.

[32]  Y. Okamoto,et al.  DNA Methylation Profiles of the Brain-Derived Neurotrophic Factor (BDNF) Gene as a Potent Diagnostic Biomarker in Major Depression , 2011, PloS one.

[33]  Xiang Wang,et al.  Evidence of a Dissociation Pattern in Resting-State Default Mode Network Connectivity in First-Episode, Treatment-Naive Major Depression Patients , 2012, Biological Psychiatry.

[34]  A. Caspi,et al.  Serotonin transporter gene moderates childhood maltreatment's effects on persistent but not single-episode depression: replications and implications for resolving inconsistent results. , 2011, Journal of affective disorders.

[35]  J. Kowalski,et al.  Association Between C-281A and Val66met Functional Polymorphisms of BDNF Gene and Risk of Recurrent Major Depressive Disorder in Polish Population , 2011, Journal of Molecular Neuroscience.

[36]  B. Penninx,et al.  Serum levels of brain-derived neurotrophic factor in major depressive disorder: state–trait issues, clinical features and pharmacological treatment , 2010, Molecular Psychiatry.

[37]  J. P. Hamilton,et al.  Investigating neural primacy in Major Depressive Disorder: Multivariate granger causality analysis of resting-state fMRI time-series data , 2010, Molecular Psychiatry.

[38]  P. Terpstra,et al.  Poor replication of candidate genes for major depressive disorder using genome-wide association data , 2011, Molecular Psychiatry.

[39]  O. Forlenza,et al.  Circulating Glial-derived neurotrophic factor is reduced in late-life depression. , 2012, Journal of psychiatric research.

[40]  O. Kitis,et al.  Smaller Hippocampus Volume Is Associated with Short Variant of 5-HTTLPR Polymorphism in Medication-Free Major Depressive Disorder Patients , 2010, Neuropsychobiology.

[41]  Peter T Fox,et al.  Abnormal resting state corticolimbic blood flow in depressed unmedicated patients with major depression: A 15O‐H2O PET study , 2012, Human brain mapping.

[42]  J. Gorman,et al.  PROINFLAMMATORY AND “RESILIENCY” PROTEINS IN THE CSF OF PATIENTS WITH MAJOR DEPRESSION , 2012, Depression and anxiety.

[43]  Alan J. Thomas,et al.  Regional cerebral blood flow in late-life depression: arterial spin labelling magnetic resonance study , 2012, British Journal of Psychiatry.

[44]  H. Baba,et al.  Correlations between brain-derived neurotrophic factor and clinical symptoms in medicated patients with major depression. , 2011, Journal of affective disorders.

[45]  D. Prvulovic,et al.  Biomarkers for major depression and its delineation from neurodegenerative disorders , 2011, Progress in Neurobiology.

[46]  Y. S. Zhu,et al.  The G-712A polymorphism of brain-derived neurotrophic factor is associated with major depression but not schizophrenia , 2011, Neuroscience Letters.

[47]  H. Baba,et al.  DURATION OF LAST DEPRESSIVE EPISODE MAY INFLUENCE SERUM BDNF LEVELS IN REMITTED PATIENTS WITH MAJOR DEPRESSION , 2012, Depression and anxiety.

[48]  A. Toga,et al.  No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression , 2011, Genes, brain, and behavior.

[49]  S. Cichon,et al.  Evidence for a Relationship Between Genetic Variants at the Brain-Derived Neurotrophic Factor (BDNF) Locus and Major Depression , 2005, Biological Psychiatry.

[50]  M. Falagas,et al.  Under‐diagnosis of common chronic diseases: prevalence and impact on human health , 2007, International journal of clinical practice.

[51]  Y. Lecrubier,et al.  Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder , 2011, International clinical psychopharmacology.

[52]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[53]  V. Šerić,et al.  Serum Brain-derived neurotrophic factor (BDNF): the severity and symptomatic dimensions of depression. , 2011, Psychiatria Danubina.

[54]  A. Simmons,et al.  Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. , 2011, Archives of general psychiatry.

[55]  D. Hu,et al.  Identifying major depression using whole-brain functional connectivity: a multivariate pattern analysis. , 2012, Brain : a journal of neurology.